When he first applied for a job at Eli Lilly, newly minted law grad Robert A. Armitage was turned down. "It was a very nice rejection letter from Lilly saying, thanks, but you're unworthy," he says with a laugh. Today, Armitage is Lilly's general counsel, and he's waging his biggest fight yet: trying to protect Zyprexa, Lilly's new top drug, against thousands of liability lawsuits by patients and a patent attack by three generic drug makers.
July 10, 2006 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Asked how often he confers with his boss at Eli Lilly and Co., General Counsel Robert A. Armitage replies dryly, “Probably more than he likes.”
The 58-year-old Armitage heads Lilly’s 230-person legal division, which in this litigation-happy age plays a role as critical to Lilly’s fate as its scientists or sales force.
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
